Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

"To effectively moisturize a dry scalp, it's important to use a gentle, sulfate-free shampoo (two to three times per week), avoid hot water, and incorporate hydrating treatments like scalp oils or ...

Stifel has launched its coverage on pre-clinical stage biotech Oruka Therapeutics (NASDAQ:ORKA) with a buy recommendation and a $49 price target, citing its lead candidates ORKA-001 and ORKA-002 ...

Alex Thompson CFA, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Oruka Therapeutics (ORKA). Alex Thompson CFA has given ...

We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological ...

These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.

In patients with psoriasis receiving immunomodulatory therapy, some immune responses to COVID-19 vaccination were positive whereas others were not.